Cao et al. found that 63.3% (19/30) of ccRCC patients exhibited positive YAP1 immunoexpression, whereas the positive rate of YAP protein expression in the normal tissues was 33.3% (10/30) [15]. This evidence concerns the gene YAP1 and nonpapillary renal cell carcinoma.